Avience Biomedicals IPO GMP Today
The Avience Biomedicals IPO GMP is ₹145 (+69.7% over the upper price band of ₹208) as of 25 Jun 2026, giving an estimated listing price of ₹353 per share. On a minimum application of 1,200 shares, that is an estimated gain of ₹1,74,000. GMP has risen by ₹60 since tracking began on 18 Jun.
Last updated
- Issue Price
- ₹208
- GMP
- ₹145
- GMP %
- +69.7%
- Est. listing
- ₹353
- Est. gain / application
- +₹1,74,000
Avience Biomedicals IPO GMP trend
Tracked for 13 days. High ₹145 on 24 Jun, low ₹0 on 14 Jun.
Avience Biomedicals IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (1,200 sh) |
|---|---|---|---|---|---|
| (latest) | ₹145 | 0 | 69.71% | ₹353 | +₹1,74,000 |
| ₹145 | +₹50 | 69.71% | ₹353 | +₹1,74,000 | |
| ₹95 | +₹23 | 45.67% | ₹303 | +₹1,14,000 | |
| ₹72 | +₹2 | 34.62% | ₹280 | +₹86,400 | |
| ₹70 | -₹15 | 33.65% | ₹278 | +₹84,000 | |
| ₹85 | 0 | 40.87% | ₹293 | +₹1,02,000 | |
| ₹85 | +₹85 | 40.87% | ₹293 | +₹1,02,000 | |
| ₹0 | 0 | 0.00% | ₹208 | ₹0 | |
| ₹0 | -₹70 | 0.00% | ₹208 | ₹0 | |
| ₹70 | +₹7 | 33.65% | ₹278 | +₹84,000 | |
| ₹63 | -₹12 | 30.29% | ₹271 | +₹75,600 | |
| ₹75 | -₹10 | 36.06% | ₹283 | +₹90,000 | |
| ₹85 | — | 40.87% | ₹293 | +₹1,02,000 |
Est. listing = upper price band (₹208) + GMP. Est. gain = GMP × 1,200 shares (2 lots, the minimum application).
Avience Biomedicals IPO subscription status
| QIB | 196.77x |
|---|---|
| bNII | 670.77x |
| sNII | 451.35x |
| Retail | 401.36x |
| Total | 385.40x |
Reading the Avience Biomedicals IPO GMP
The grey market premium is the price above the issue price at which Avience Biomedicals IPO shares are informally traded before listing. A GMP of ₹145 on an upper band of ₹208 suggests the shares could open around ₹353, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand, and SME GMP in particular can swing sharply on low volumes. Check it together with the subscription numbers and the company's financials before applying.
Avience Biomedicals IPO GMP: FAQs
- What is Avience Biomedicals IPO GMP today?
- The latest grey market premium (GMP) for the Avience Biomedicals IPO is ₹145 as of 25 June 2026, which is 69.71% over the upper price band of ₹208.
- What is the expected listing price of Avience Biomedicals IPO?
- Based on the current GMP, the estimated listing price of Avience Biomedicals IPO is ₹353 per share (₹208 issue price + ₹145 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Avience Biomedicals IPO?
- The lot size is 600 shares. The minimum application is 2 lots (1,200 shares), which costs ₹2,49,600 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.